Navigation Links
Cephalon Completes Acquisition of Arana Therapeutics
Date:8/10/2009

FRAZER, Pa., Aug. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has completed its previously announced acquisition of all of the outstanding ordinary shares of Australian biotechnology company, Arana Therapeutics Limited. As a result of the acquisition, Arana is now a wholly-owned subsidiary of Cephalon.

Cephalon Chairman and CEO, Frank Baldino Jr., Ph.D., said, "We are excited about the advanced biological and molecular technology expertise that Arana brings to Cephalon. With biologics in inflammatory diseases and clinical candidates in oncology for solid tumors, this acquisition will catalyze the entry of Cephalon into the biologics space."

Cephalon acquires an established protein engineering technology platform to transform proteins, including antibodies, into potent drug candidates. The lead biologic in the portfolio (ART621) is the first domain antibody to enter the clinic targeting TNF alpha, and is in a phase 2 clinical program for rheumatoid arthritis. Additional biologics acquired include: a RANKL inhibitor for bone metastases; one targeting a novel epitope for colorectal cancer in collaboration with Kyowa Hakko-Kirin; one targeting gangliosides for small cell lung cancer and melanoma; one targeting IL 12 /23 for psoriasis and Crohn's disease as well as other earlier stage opportunities.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune 1000 and the S&P 500 Index, Cephalon currently employs approximately 3,000 people in the United States and Europe.
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... allows users to easily find and schedule an appointment for ... health screening, share comments, view personal stories, and connect with ... health screening company’s new site will improve its usability, ... ... OH (PRWEB) December 17, 2009 -- Visitors to Life Line ...
(Date:12/17/2009)... will be exhibiting the latest particle size distribution technologies, including ... Scientists’ Annual Meeting, AAPS 2010. , ... ... exhibiting at the American Association of Pharmaceutical Scientists’ Annual ... 2010. Visit Booth 612 at AAPS 2010 to see ...
(Date:12/16/2009)... It has passed as fact among historians, journalists and ... to the floor of the U.S. Congress: British forces ... I. , But that claim has never been ... Douglas, a historian at Colgate University. According to Douglas,s ... Journal of Modern History , no such incident ever ...
(Date:12/16/2009)... scientists at the University of East Anglia (UEA) could ... or agricultural waste to generate clean electricity. , Published ... the National Academy of Sciences (PNAS), the researchers ... which some bacteria survive by ,breathing rocks,. , The ... of new microbe-based technologies such as fuel cells, or ...
Breaking Biology Technology:Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2
... ARBOR, Mich., April 16 Lycera Corp. today announced ... company, which is developing novel small-molecule pharmaceuticals to treat ... disease, has received $10 million as a first tranche ... the proceeds in two tranches as specific milestones are ...
... Implanted through the Smallest Micro-Incision using nanoPOINT(TM)Pricing of ... PracticesMONROVIA, Calif., April 16 STAAR Surgical Company ... manufacturer and marketer of minimally invasive ophthalmic products, ... Aspheric Single Piece New Technology Intraocular Lens (NTIOL). ...
... company Solidus Bioscience Inc have successfully implemented Amphora,s ... Solidus are using PatentSafe as a fully electronic ... this fit more efficiently into today,s laboratories but ... their data simply and effectively, saving significant time ...
Other Biology Technology:Lycera Closes $36 Million Series A Financing 2Lycera Closes $36 Million Series A Financing 3Lycera Closes $36 Million Series A Financing 4STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL 2STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL 3STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL 4STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL 5Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 2Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 3
(Date:12/16/2009)... Society has announced the winners of its student travel ... at the Moscone Convention Center in San Francisco, California, ... are selected based on scientific merit, with priority given ... conference. Each awardee receives a travel grant and ... 20. , The 2010 recipients of the Student Travel ...
(Date:12/16/2009)... a high priority for grape growers in the southern Napa Valley, ... irrigated to make it through the growing season. But Stanford researchers ... the vines zips right by the plants, hardly even pausing. ... is applied is lost below the vine rooting zone and does ... Hinckley, who worked on the project for her PhD thesis in ...
(Date:12/16/2009)... form an intricate network of interactions. Today,s techniques, ... molecular reactions outside the cells. Since molecular concentrations ... laboratory, scientists suspect that the kinetics of molecular ... probes. We expected the cellular reaction speed to ... "However, our novel optical approach showed that ...
Breaking Biology News(10 mins):Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4Looking for the heartbeat of cellular networks 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 1Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 3Study shows promise for new cancer stopping therapy 48649 1Study shows promise for new cancer stopping therapy 48649 2Study finds segregation decreases access to surgical care for minorities 48646 1Study finds segregation decreases access to surgical care for minorities 48646 2
... bones, the skeletons of organisms contain small amounts of ... these elements provide important clues to past environments, a ... impurity contents to the ancient environments in which an ... of Science magazine, Allison Stephenson, a Ph.D. ...
... bacteria in the root of a tropical grass whose ... industries. These bacteria seem to promote the production of ... of the oil, giving it different flavours and properties: ... of the tropical Vetiver grass through interdisciplinary research, the ...
... Helmholtz-Zentrum fr Infektionsforschung (HZI) in Braunschweig, Germany have ... pathways in bacteria and their use. Using computer ... headed up by Vtor Martins dos Santos, calculated ... the production of biosynthetics in the Pseudomonas ...
Other Biology News:Bare bones of crystal growth: Biomolecules enhance metal contents in calcite 2Bacteria manage perfume oil production from grass 2Biosynthetics production with detours 2
... of human cullin genes (CUL-1, -2, -3, -4a, -4b, ... Cullin-3 is proposed to be a part of E3 ... E and targets it for ubiquitination, which leads to ... of cdk2, which leads the cell to S phase. ...
Imject Freund's Incomplete Adjuvant (FIA)...
With sodium bicarbonate. Sterile, Cell culture tested...
A substrate for all AChE-based EIA kits....
Biology Products: